Insulin therapy in type II diabetes.
When diet therapy is no longer effective in keeping the fasting plasma glucose level < 6 mmol l-1, a basal insulin supplement from a long-acting insulin such as ultralente can be added instead of using a sulphonylurea or metformin. The dose of insulin required can be predicted from the level...
Auteurs principaux: | Holman, R, Turner, R |
---|---|
Format: | Conference item |
Publié: |
1995
|
Documents similaires
-
Intermediate acting insulin for type 2 diabetes.
par: Turner, R, et autres
Publié: (1985) -
DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
par: Eeley, E, et autres
Publié: (1992) -
UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
par: Cull, C, et autres
Publié: (1995) -
Addition of insulin to oral therapy in type 2 diabetes - Reply
par: Holman, R, et autres
Publié: (2008) -
Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
par: Holman, R, et autres
Publié: (1987)